Products
Tulobuterol is commercially available as a syrup (Brelomax). The active ingredient is not registered in many countries.
Structure and properties
Tulobuterol (C12H18ClNO, Mr = 227.7 g/mol)
Effects
Tulobuterol (ATC R03CC11) is selectively sympathomimetic at beta2 receptors. It relaxes bronchial muscles, inhibits mediator release, and increases mucociliary transport.
Indications
Airway constriction due to bronchial muscle spasm (obstructive airway disease).